Noxopharm has previously said that their clinical focus would shift to radiology in the first instance after talking to physicians. This is because late stage patients are commonly offered radiation rather than chemo. The CEP trial is still ongoing, and this is discussed in the preso.
Big whoop.
Ann: Corporate Presentation - Post Interim Clinical Data Release, page-5
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NOX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $29.22M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 52445 | 10.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 11.0¢ | 46575 | 3 |
View Market Depth
| Last trade - 11.05am 27/11/2024 (20 minute delay) ? |
| NOX (ASX) Chart |
Day chart unavailable
